X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
ASTRAZENECA PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 66.7%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Markets will remain closed on 19th April, 2019 on account of Good Friday.

ASTRAZENECA PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 66.7%
Tue, 27 Nov

ASTRAZENECA PHARMA has announced its results for the quarter ended September 2018. Here is a detailed performance review of the same:

ASTRAZENECA PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Sep-17*
3
Jun-18*
3
Sep-18*
QoQ ChangeYoY Change
Net SalesRs m1,6431,6141,6140.0%-1.8%
Other incomeRs m253434-2.0%34.4%
TurnoverRs m1,6681,6491,647-0.1%-1.2%
ExpensesRs m1,2861,5221,466-3.7%14.0%
Gross profitRs m3579314859.1%-58.6%
DepreciationRs m3736373.5%-2.0%
InterestRs m0000.0%0.0%
Profit before taxRs m3449214457.8%-58.0%
TaxRs m70285392.5%-24.2%
Profit after taxRs m274649142.8%-66.7%
Gross profit margin%21.75.79.1
Effective tax rate%20.430.136.8
Net profit margin%16.43.95.5
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter fell 1.8% on a year-on-year (YoY) basis. The expenses were up by 14.0% YoY during the same period.
  • The company's operating profit declined by 58.6% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 9.1% in 2QFY19 as against 21.7% in 2QFY18.
  • Depreciation charges declined by 2.0% and finance costs increased by 0.0% YoY, respectively.
  • Other income increased by 34.4% YoY during the quarter.
  • Net profit for the quarter declined by 66.7% YoY. Net profit margins during the quarter declined from 16.4% in 2QFY18 to 5.5% in 2QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 0.0% on a quarter-on-quarter (QoQ) basis. The expenses were down by 3.7% QoQ during the same period.
  • The company's operating profit increased by 59.1% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 9.1% in 2QFY19 as against 5.7% in 1QFY18.
  • Net profit for the quarter increased by 42.8% QoQ, while net profit margins increased from 3.9% in 1QFY18 to 5.5% in 2QFY19.

To see how ASTRAZENECA PHARMA has performed over the last eight quarters, please visit here.

ASTRAZENECA PHARMA Share Price Performance

Over the last one year, ASTRAZENECA PHARMA share price has moved up from Rs 1,144.2 to Rs 1,466.2, registering a Gain of Rs 322.1 or around 28.1%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 14,047.4 (down 0.9%). Over the last one year it has moved down from 14,073.9 to 14,047.4, a gain of 27 points (down 0.2%).

Overall, the S&P BSE SENSEX is up 5.2% over the year.

Current Valuations

At the current price of Rs 1,466.2, the price to earnings (P/E) ratio of ASTRAZENECA PHARMA stands at 436.6 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 21.4 times.

Equitymaster requests your view! Post a comment on "ASTRAZENECA PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 66.7%". Click here!

  

Related Views on News

ASTRAZENECA PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Mar 29, 2019 | Updated on Mar 29, 2019

Here's an analysis of the annual report of ASTRAZENECA PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of ASTRAZENECA PHARMA. Also includes updates on the valuation of ASTRAZENECA PHARMA.

ASTRAZENECA PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 381.0% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ASTRAZENECA PHARMA has posted a net profit of Rs 291 m (up 381.0% YoY). Sales on the other hand came in at Rs 2 bn (up 67.4% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 10.3% (Quarterly Result Update)

Aug 21, 2018 | Updated on Aug 21, 2018

For the quarter ended June 2018, ASTRAZENECA PHARMA has posted a net profit of Rs 64 m (up 10.3% YoY). Sales on the other hand came in at Rs 2 bn (up 25.7% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Stocks that Could Be Out of Reach Post Elections(The 5 Minute Wrapup)

Apr 9, 2019

It's a matter of time before the stocks catch the fancy of the markets and big investors.

3 Indian Stocks with Amazon-Like Potential(Profit Hunter)

Apr 10, 2019

We have identified 3 stocks with huge wealth building potential which meet our 'Click of a Button' criteria.

A 90% Chance of Auto Stocks Moving Up This April(Profit Hunter)

Apr 5, 2019

The Auto index ended on a positive note in the month of April in 9 out of last 10 years. This Auto stock is best placed to benefit from the upswing in this sector.

This Company is Making a Big Comeback and You Can Now Profit from Its Example(The 5 Minute Wrapup)

Apr 10, 2019

How Dell got its mojo back.

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ASTRAZENECA PHARMA SHARE PRICE


Apr 18, 2019 03:37 PM

TRACK ASTRAZENECA PHARMA

  • Track your investment in ASTRAZENECA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ASTRAZENECA PHARMA

ASTRAZENECA PHARMA - MYLAN COMPARISON

COMPARE ASTRAZENECA PHARMA WITH

MARKET STATS